After nearly eight years of careful planning, guests from across Illinois gathered today in Lake Forest to celebrate the ceremonial opening of the new Northwestern Medicine Lake Forest Hospital, which will officially open on March 3, 2018.
The new state-of-the-art hospital, which broke ground in 2014, will provide patients convenient access to world-class physicians with seamless access to Northwestern Memorial Hospital, Illinois’s premier academic medical center when needed. The new Lake Forest Hospital will offer cutting-edge treatments and innovative clinical trials within a world class health system.
To view the multimedia release go to:
https://www.multivu.com/players/English/8213351-new-northwestern-medicine-lake-forest-hospital/
TransCelerate BioPharma Inc., a non-profit organization dedicated to improving the health of people around the world by simplifying and accelerating research and development of innovative new therapies, has unveiled a new global campaign designed to help increase awareness of the growing need for clinical trial participants. The campaign, called “One Person Closer,” focuses on inspiring healthcare professionals (HCPs) to consider clinical research as a possibility for their patients, incorporate the topic into their daily practices, and have meaningful conversations with patients about opportunities to participate in clinical trials.
One Person Closer is designed to put a human face on research and development by sharing the personal stories of researchers, HCPs and patients who have contributed to clinical research and the development of medical breakthroughs. The photojournalist campaign aims to show doctors, nurses and other HCPs that they can help facilitate research that advances science and that may benefit their patients.
To view the multimedia release go to:
https://www.multivu.com/players/English/8268751-transcelerate-biopharma-one-person-closer/
Let’s Win, an initiative supported by the Lustgarten Foundation, launched the Let’s Win! Pancreatic Cancer Survivors video series Friday, January 19, 2018, at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium. The new online video series, featuring long-term pancreatic cancer survivors of all ages and diverse backgrounds, has been created to show pancreatic cancer patients and their families that people do survive this disease. The survivors have responded exceptionally well to pancreatic cancer therapy that incorporates clinical trials and treatments that go beyond traditional protocols.
When patients are first diagnosed with pancreatic cancer, they often turn to the internet, only to find devastating and frightening statistics about the disease. “Our goal is to provide hope and inspiration to patients and their families,” says Cindy Gavin, founding executive director of Let’s Win. “We are so grateful for the incredible vision of one special patient and the generosity of The Flora Family Foundation for their support of this incredible initiative.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213752-lets-win-pancreatic-cancer-survivor-video-series/
Sickle cell disease (SCD) is an inherited, lifelong chronic disorder affecting nearly 100,000 Americans and a growing global health problem that will touch nearly 30 percent more people globally in the next three decades. Though new approaches to managing SCD have led to improvements in diagnosis and supportive care, people living with the disease still have severe complications to overcome. Many are unable to access quality care and are limited by a lack of effective treatment options.
In an effort to identify unmet medical needs for people with SCD, the American Society of Hematology (ASH), along with other groups, issued the State of Sickle Cell Disease: 2016 Report, evaluating the disease in four priority areas — access to care, training and professional education, research and clinical trials, and global health. The report shows that significant improvements are needed across all areas and that, though patients are living longer, the system of care needs to change to ensure a better quality of life. To address these challenges, ASH launched the Sickle Cell Disease Coalition along with more than 20 other organizations who are issuing a call to action that will amplify the voice of the SCD community, promote SCD awareness, and transform SCD care both in the United States and around the globe.
To view the multimedia release go to:
http://www.multivu.com/players/English/7903251-american-society-hematology-sickle-cell-coalition/
Combining their expertise in clinical trials support and cellular therapies, BloodCenter of Wisconsin (BCW) and the San Diego Blood Bank (SDBB) have created a strategic partnership to accelerate advancements in research and patient care. Together, BloodCenter of Wisconsin and San Diego Blood Bank will offer Celluvative™ – a portfolio of products and clinical trial services that will include esoteric laboratory testing, blood products for research and manufacturing applications, cell processing, and access to a broad database of diverse donors who have expressed interest in clinical trials.
“Through the strength of our partnership, we are able to offer end-to-end services to academic organizations, research institutions and other industry partners who are working to develop novel cellular therapy approaches,” said Matthew Anderson, M.D., Ph.D., medical director, BloodCenter of Wisconsin Diagnostic Laboratories. “Among other offerings, our Celluvative portfolio enables access to an extremely diverse donor database – an invaluable resource to enable advances in the area of regenerative medicine and drug discovery.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7855451-bloodcenter-sdbb-celluvative/
As infants they were smuggled out of a cult by their aunt. Their mother was murdered by the cult leader, their father. In hiding, Ivy and her twin sister Amber are taught how to fight. How to stay alive. But at 16 some of life’s trials are unexpected. Like love. And the ability to heal with a touch. When her father kidnaps their adoptive parents and forces them to come to the cult compound, Ivy makes a mistake with her power that ends in tragedy, and brings about her sister’s unusual power with the dead. Find out more at http://www.SheilaEnglish.com Keeper of the Light Book 1 of The Faith Healer’s Daughters trilogy. Paranormal/fantasy
Click: http://entertheparadox.com/ The video follows the story of a young man named Fibonacci. Through his trials and tribulations, Fibonacci discovers the lessons of love, loyalty and mayhem.
Showcasing a melting pot of styles of cutting-edge rock, psychedelic, pop-punk, and hardcore fused together, Enter The Paradox bring their sound together in ways never before heard.
Eyeing vast new efficiencies in global fresh produce and fresh-cut flower transport, Maersk Container Industry (MCI) is now partnering with Boston-based technology company Primaira LLC to develop an air cleaning system in Star Cool Integrated refrigerated containers.
Thorough tests and trials have shown the patented technology, Bluezone®, to be an efficient eliminator of molds, fungi and bacteria. Using an ozone concentration 300 times higher than otherwise seen on the market, Bluezone also removes ethylene effectively.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64186-maersk-container-launch-new-technology
Following a rigorous season of trials and qualification events, six of the competing Team Kellogg’s™ U.S. Olympic athletes have demonstrated from great starts come great things by being named to Team USA™. With the Opening Ceremony for the Sochi 2014 Olympic Winter Games just days away on Feb. 7, these U.S. Olympic athletes have earned the chance to be among those proudly representing their country.
To view Multimedia News Release, go to http://www.multivu.com/players/English/65305-kellogg-s-team-usa-sochi-2014-winter-olympics/
In recent years there has been a shift in the understanding of cancer. Immunotherapy with vaccines has been emerging as the most promising direction towards a decisive improvement of treatment outcomes.
The Dendritic Cell Vaccine has received FDA approval for prostate cancer and trials are now under way for a variety of other cancers. These vaccines are usually administered on their own.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64654-issels-integrative-immunotherapy-for-standard-therapy-resistant-cancers
What\'s the wisdom of Allah in these testing times??
A session by Daee Ahmed Moait covering topics:
- The Ummah in tribulations ..
- The Mercy taught to us by our teacher, Muhammad SAW
- Sanctity of a soul ...
- are the animals and beasts laughing at us??
- Verses from Qur\'an about the hypocrites and the people who are veiled
- trials to some, Mercy to some...
What's the wisdom of Allah in these testing times??
A session by Daee Ahmed Moait covering topics:
- The Ummah in tribulations ..
- The Mercy taught to us by our teacher, Muhammad SAW
- Sanctity of a soul ...
- are the animals and beasts laughing at us??
- Verses from Qur'an about the hypocrites and the people who are veiled
- trials to some, Mercy to some...
